SARS CoV-2 infections in animals, two years into the pandemic

S Frazzini, M Amadori, L Turin, F Riva - Archives of Virology, 2022 - Springer
In December 2019, several cases of pneumonia caused by a novel coronavirus, later
identified as SARS-CoV-2, were detected in the Chinese city of Wuhan. Due to its rapid …

Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants

R Yin, BY Feng, A Varshney, BG Pierce - Protein Science, 2022 - Wiley Online Library
High‐resolution experimental structural determination of protein–protein interactions has led
to valuable mechanistic insights, yet due to the massive number of interactions and …

[HTML][HTML] Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors

JR Willis, ZT Berndsen, KM Ma, JM Steichen… - Immunity, 2022 - cell.com
Broadly neutralizing antibodies (bnAbs) to the HIV envelope (Env) V2-apex region are
important leads for HIV vaccine design. Most V2-apex bnAbs engage Env with an …

Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice

E Melzi, JR Willis, KM Ma, YC Lin, S Kratochvil… - Immunity, 2022 - cell.com
Eliciting broadly neutralizing antibodies (bnAbs) is the core of HIV vaccine design. bnAbs
specific to the V2-apex region of the HIV envelope acquire breadth and potency with modest …

Glycans in HIV-1 vaccine design–engaging the shield

LP Deimel, X Xue, QJ Sattentau - Trends in Microbiology, 2022 - cell.com
Glycans are repeating carbohydrate structures added as post-translational modifications
(PTMs) to proteins, forming glycoproteins. Self-glycans found on human cells, and viral …

Analysis of B cell receptor repertoires reveals key signatures of the systemic B cell response after SARS-CoV-2 infection

Y Zhang, Q Yan, K Luo, P He, R Hou, X Zhao… - Journal of …, 2022 - Am Soc Microbiol
ABSTRACT A comprehensive study of the B cell response against SARS-CoV-2 could be
significant for understanding the immune response and developing therapeutical antibodies …

Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller

V Lorin, I Fernández, G Masse-Ranson… - Journal of Experimental …, 2022 - rupress.org
Decrypting the B cell ontogeny of HIV-1 broadly neutralizing antibodies (bNAbs) is
paramount for vaccine design. Here, we characterized IgA and IgG bNAbs of three distinct B …

Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein

R Otsubo, T Minamitani, K Kobiyama, J Fujita, T Ito… - Scientific Reports, 2022 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). Variants of concern (VOCs) such as Delta and Omicron have …

Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo

A Herschhorn - ACS Infectious Diseases, 2022 - ACS Publications
HIV-1 continues to be a major public health concern, with approximately 37.7 million people
living with HIV-1 worldwide at the end of 2021 (www. who. int). Broadly neutralizing …

Structural dynamics reveal isolate-specific differences at neutralization epitopes on HIV Env

EA Hodge, GS Naika, SM Kephart, A Nguyen, R Zhu… - Iscience, 2022 - cell.com
The envelope glycoprotein (Env) is the sole target for neutralizing antibodies against HIV
and the most rapidly evolving, variable part of the virus. High-resolution structures of Env …